UNDERWRITING AGREEMENTUnderwriting Agreement • February 13th, 2018 • Scythian Biosciences Corp. • Pharmaceutical preparations • Ontario
Contract Type FiledFebruary 13th, 2018 Company Industry Jurisdiction
UNDERWRITING AGREEMENTUnderwriting Agreement • January 23rd, 2018 • Ontario
Contract Type FiledJanuary 23rd, 2018 JurisdictionClarus Securities Inc. (“Clarus” or the “Lead Underwriter”), Haywood Securities Inc., and INFOR Financial Inc. (collectively, the “Underwriters” and each, an “Underwriter”) understand that Scythian Biosciences Corp. (the “Corporation” or “Scythian”) proposes to issue and sell 672,125 units of the Corporation (the “Units”) at a price of $18.60 per Unit. Each Unit is comprised of one common share (a “Common Share”) in the capital of the Corporation and one Common Share purchase warrant (the “Warrants”) with each Warrant being exercisable into one Common Share (a “Warrant Share”) at an exercise price of $22.00 per Warrant Share for a period of twenty four (24) months after the Closing Date (as defined herein).